Biotissue Holdings, Inc
Clinical trials sponsored by Biotissue Holdings, Inc, explained in plain language.
-
New eye drop shows promise for dry eye relief
Symptom relief CompletedThis study tested a new eye drop called TTAX03 in 74 people with mild to moderate dry eye disease. The main goal was to see if it is safe, and researchers also looked at how well it works compared to a saline (salt water) control. Participants received a single dose and were foll…
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated May 26, 2026 11:27 UTC
-
New knee shot aims to ease arthritis pain in severe cases
Symptom relief CompletedThis study tested a single injection of TTAX03 in the knee for people with severe osteoarthritis (grades 3-4). 90 adults received either the study drug or a placebo (saline). The goal was to see if more people reported significant pain relief or better function after 12 weeks. Th…
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC